JUSTIN EARL BIRD to Molecular Targeted Therapy
This is a "connection" page, showing publications JUSTIN EARL BIRD has written about Molecular Targeted Therapy.
Connection Strength
0.076
-
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer. 2018 Sep 24; 18(1):913.
Score: 0.076